Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma

被引：0
|
作者：
Vadim S. Koshkin
Petros Grivas
机构：
[1] Cleveland Clinic Taussig Cancer Institute,Department of Medicine, Division of Oncology, Seattle Cancer Care Alliance
[2] University of Washington and Fred Hutchinson Cancer Research Center,undefined
来源：
Current Oncology Reports | 2018年 / 20卷
关键词：
Metastatic bladder cancer; Advanced urothelial carcinoma; Immunotherapy; Immune checkpoint inhibitors; PD-1; PD-L1; Cisplatin-ineligible; Platinum-refractory; Atezolizumab; Pembrolizumab; Avelumab; Nivolumab; Durvalumab; Biomarkers; clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Emerging Role of Immunotherapy in Advanced Urothelial Carcinoma
    Koshkin, Vadim S.
    Grivas, Petros
    [J]. CURRENT ONCOLOGY REPORTS, 2018, 20 (06)
  • [2] Emerging role of immunotherapy in urothelial carcinoma-Advanced disease
    Zibelman, Matthew
    Ramamurthy, Chethan
    Plimack, Elizabeth R.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (12) : 538 - 547
  • [3] The emerging role of immunotherapy in advanced urothelial cancers
    Tabayoyong, William
    Gao, Jianjun
    [J]. CURRENT OPINION IN ONCOLOGY, 2018, 30 (03) : 172 - 180
  • [4] Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers
    Sweis, Randy F.
    Galsky, Matthew D.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (12) : 556 - 565
  • [5] Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer
    Giridhar, Karthik V.
    Kohli, Manish
    [J]. MAYO CLINIC PROCEEDINGS, 2017, 92 (10) : 1564 - 1582
  • [6] THE ROLE OF TERT PROMOTER MUTATION IN ADVANCED UROTHELIAL CARCINOMA TREATED WITH IMMUNOTHERAPY
    Marchese, Paola Valeria
    Mollica, Veronica
    De Biase, Dario
    Giunchi, Francesca
    Nuvola, Giacomo
    Marchetti, Andrea
    Rosellini, Matteo
    Tassinari, Elisa
    Fiorentino, Michelangelo
    Massari, Francesco
    [J]. ANTICANCER RESEARCH, 2022, 42 (10) : 5140 - 5140
  • [7] Emerging role of immunotherapy in urothelial carcinoma-Future directions and novel therapies
    Park, Jong Chul
    Hahn, Noah M.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (12) : 566 - 576
  • [8] Update of systemic immunotherapy for advanced urothelial carcinoma
    Gartrell, Benjamin A.
    He, Tianfang
    Sharma, Janaki
    Sonpavde, Guru
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (12) : 678 - 686
  • [9] The emerging treatment landscape of advanced urothelial carcinoma
    Cardenas, Luisa
    Dibajnia, Pooya
    Lalani, Aly-Khan
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2021, 15 (04) : 247 - 252
  • [10] Targeted and immunotherapy for the management of advanced urothelial carcinoma of the bladder
    Cersosimo, Robert J.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024,
12345